Stay updated on Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page
- Check3 days agoChange DetectedUpdate page revision from v3.0.1 to v3.0.2; remove the old 'Revision: v3.0.1' line and the 'Back to Top' element.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has updated the facility name and location details, specifically changing from 'Saint Louis, Missouri' to 'St Louis, Missouri'. Additionally, the drug 'sitravatinib' has been added, indicating a potential update in treatment options.SummaryDifference1%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.